BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33540939)

  • 1. Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
    Veeroju S; Kojonazarov B; Weiss A; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Novoyatleva T; Schermuly RT
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
    Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
    Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorogenic acid inhibits hypoxia-induced pulmonary artery smooth muscle cells proliferation via c-Src and Shc/Grb2/ERK2 signaling pathway.
    Li QY; Zhu YF; Zhang M; Chen L; Zhang Z; Du YL; Ren GQ; Tang JM; Zhong MK; Shi XJ
    Eur J Pharmacol; 2015 Mar; 751():81-8. PubMed ID: 25666384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor up-regulates Ca
    Yamamura A; Nayeem MJ; Al Mamun A; Takahashi R; Hayashi H; Sato M
    FASEB J; 2019 Jun; 33(6):7363-7374. PubMed ID: 30865840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Src tyrosine kinases in experimental pulmonary hypertension.
    Pullamsetti SS; Berghausen EM; Dabral S; Tretyn A; Butrous E; Savai R; Butrous G; Dahal BK; Brandes RP; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Rosenkranz S; Schermuly RT
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1354-65. PubMed ID: 22516066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
    Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
    Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
    Grobs Y; Awada C; Lemay SE; Romanet C; Bourgeois A; Toro V; Nadeau V; Shimauchi K; Orcholski M; Breuils-Bonnet S; Tremblay E; Provencher S; Paulin R; Boucherat O; Bonnet S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Factor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells.
    Li Y; Li L; Qian Z; Lin B; Chen J; Luo Y; Qu J; Raj JU; Gou D
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension.
    Kovacs L; Han W; Rafikov R; Bagi Z; Offermanns S; Saido TC; Black SM; Su Y
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):384-93. PubMed ID: 26248159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
    Yamamura A; Nayeem MJ; Sato M
    Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Rho kinase and Na+/H+ exchange in hypoxia-induced pulmonary arterial smooth muscle cell proliferation and migration.
    Walker J; Undem C; Yun X; Lade J; Jiang H; Shimoda LA
    Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27009277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
    Ye C; Lian G; Wang T; Chen A; Chen W; Gong J; Luo L; Wang H; Xie L
    BMC Pulm Med; 2022 Mar; 22(1):111. PubMed ID: 35346134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension.
    Weiss A; Neubauer MC; Yerabolu D; Kojonazarov B; Schlueter BC; Neubert L; Jonigk D; Baal N; Ruppert C; Dorfmuller P; Pullamsetti SS; Weissmann N; Ghofrani HA; Grimminger F; Seeger W; Schermuly RT
    Nat Commun; 2019 May; 10(1):2204. PubMed ID: 31101827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGF/MEK/ERK axis represses Ca
    Deng L; Chen J; Wang T; Chen B; Yang L; Liao J; Chen Y; Wang J; Tang H; Yi J; Kang K; Li L; Gou D
    Am J Physiol Cell Physiol; 2021 Jan; 320(1):C66-C79. PubMed ID: 32966125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.